{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:37:20Z","timestamp":1789270640999,"version":"build-2803163510"},"reference-count":81,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T00:00:00Z","timestamp":1430870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Valeant Pharmaceuticals North America LLC"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Atopic dermatitis (AD) is one of the most common skin diseases affecting infants and children. A smaller subset of adults has persistent or new-onset AD. AD is characterized by pruritus, erythema, induration, and scale, but these features are also typical of several other conditions that can mimic, coexist with, or complicate AD. These include inflammatory skin conditions, infections, infestations, malignancies, genetic disorders, immunodeficiency disorders, nutritional disorders, graft-versus-host disease, and drug eruptions. Familiarity of the spectrum of these diseases and their distinguishing features is critical for correct and timely diagnosis and optimal treatment.<\/jats:p>","DOI":"10.3390\/jcm4050884","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T10:58:41Z","timestamp":1430909921000},"page":"884-917","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Diagnosis of Atopic Dermatitis: Mimics, Overlaps,  and Complications"],"prefix":"10.3390","volume":"4","author":[{"given":"Elaine","family":"Siegfried","sequence":"first","affiliation":[{"name":"Saint Louis University, Cardinal Glennon Children's Hospital, 1465 South Grand Avenue,  St. Louis, MO 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide","family":"Hebert","sequence":"additional","affiliation":[{"name":"University of Texas-Houston Medical School, 6655 Travis, Suite 980, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,5,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jid.2010.251","article-title":"Eczema prevalence in the United States: Data from the 2003 National Survey of Children\u2019s Health","volume":"131","author":"Shaw","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1398-9995.2008.01880.x","article-title":"Gender difference, sex hormones, and immediate type hypersensitivity reactions","volume":"63","author":"Chen","year":"2008","journal-title":"Allergy"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0190-9622(03)02539-8","article-title":"Consensus conference on pediatric atopic dermatitis","volume":"49","author":"Eichenfield","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies","volume":"71","author":"Eichenfield","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jaad.2014.08.038","article-title":"Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches","volume":"71","author":"Sidbury","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/pde.12216","article-title":"Retrospective analysis of the relationship between infantile seborrheic dermatitis and atopic dermatitis","volume":"31","author":"Alexopoulos","year":"2014","journal-title":"Pediatr. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1590\/S0365-05962011000600002","article-title":"Seborrheic dermatitis","volume":"86","author":"Sampaio","year":"2011","journal-title":"An. Bras. Dermatol."},{"key":"ref_8","first-page":"756","article-title":"Topical antifungal agents for seborrheic dermatitis: Systematic review and meta-analysis","volume":"94","author":"Apasrawirote","year":"2011","journal-title":"J. Med. Assoc. Thail."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kastarinen, H., Oksanen, T., Okokon, E.O., Kiviniemi, V.V., Airola, K., Jyrkka, J., Oravilahti, T., Rannanheimo, P.K., and Verbeek, J.H. (2014). Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp. Cochrane Database Syst. Rev., 5.","DOI":"10.1002\/14651858.CD009446.pub2"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2340\/00015555-0770","article-title":"Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany","volume":"90","author":"Augustin","year":"2010","journal-title":"Acta Derm. Venereol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaci.2011.01.053","article-title":"Contrasting pathogenesis of atopic dermatitis and psoriasis\u2014Part I: Clinical and pathologic concepts","volume":"127","author":"Nograles","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_12","first-page":"172","article-title":"Facing psoriasis and atopic dermatitis: Are there more similarities or more differences?","volume":"18","author":"Hagemann","year":"2008","journal-title":"Eur. J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00128071-200102020-00008","article-title":"Calcipotriol ointment. A review of its use in the management of psoriasis","volume":"2","author":"Scott","year":"2001","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1468-3083.2012.04640.x","article-title":"Combinations of classical time-honoured topicals in plaque psoriasis: A systematic review","volume":"27","author":"Hendriks","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2310\/7750.2013.13059","article-title":"Efficacy of topical calcineurin inhibitors in psoriasis","volume":"18","author":"Wang","year":"2014","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1529-8019.2006.00058.x","article-title":"The differential diagnosis of atopic dermatitis in childhood","volume":"19","author":"Krol","year":"2006","journal-title":"Dermatol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.iac.2010.06.001","article-title":"The role of contact allergy in atopic dermatitis","volume":"30","author":"Fonacier","year":"2010","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/ACI.0b013e328357b05a","article-title":"Contact dermatitis in atopic individuals","volume":"12","author":"Spiewak","year":"2012","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/pai.12043","article-title":"Allergic contact dermatitis in children: Which factors are relevant? (review of the literature)","volume":"24","author":"Andersen","year":"2013","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jaip.2014.05.004","article-title":"The role of contact dermatitis in patients with atopic dermatitis","volume":"2","author":"Aquino","year":"2014","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_21","first-page":"3","article-title":"Allergic contact dermatitis in children: A practical approach to management","volume":"7","author":"Bruckner","year":"2002","journal-title":"Skin Ther. Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1824-7288-36-2","article-title":"Contact dermatitis in children","volume":"36","author":"Pigatto","year":"2010","journal-title":"Ital. J. Pediatr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clindermatol.2010.07.004","article-title":"Dry skin, barrier function, and irritant contact dermatitis in the elderly","volume":"29","author":"Seyfarth","year":"2011","journal-title":"Clin. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1600-0536.2011.01963.x","article-title":"Contact allergy and allergic contact dermatitis in children\u2014A review of current data","volume":"65","author":"Simonsen","year":"2011","journal-title":"Contact Dermatitis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-0536.1995.tb00784.x","article-title":"Efficacy of topical corticosteroids on irritant skin reactions","volume":"32","author":"Ramsing","year":"1995","journal-title":"Contact Dermatitis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1034\/j.1600-0536.2000.043006317.x","article-title":"An overview of the efficacy of topical corticosteroids in experimental human nickel contact dermatitis","volume":"43","author":"Levin","year":"2000","journal-title":"Contact Dermatitis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2310\/6620.2004.03007","article-title":"Efficacy of tacrolimus ointment in the prevention and treatment of contact dermatitis","volume":"15","author":"Anderson","year":"2004","journal-title":"Dermatitis"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2310\/7750.2008.07026","article-title":"Use of pimecrolimus cream in disorders other than atopic dermatitis","volume":"12","author":"Day","year":"2008","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11882-012-0305-0","article-title":"Current strategies in treating severe contact dermatitis in pediatric patients","volume":"12","author":"Fonacier","year":"2012","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_30","first-page":"221","article-title":"Symptomatic dermatographism: Current concepts in clinical practice with an emphasis on the pediatric population","volume":"87","author":"Mecoli","year":"2011","journal-title":"Cutis"},{"key":"ref_31","first-page":"21","article-title":"Pityriasis alba","volume":"76","author":"Lin","year":"2005","journal-title":"Cutis"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1365-4632.2007.03145.x","article-title":"An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba","volume":"46","author":"Fujita","year":"2007","journal-title":"Int. J. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2133.2006.07181.x","article-title":"Tacrolimus ointment 0.1% in pityriasis alba: An open-label, randomized, placebo-controlled study","volume":"155","author":"Rigopoulos","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1440-0960.2012.00878.x","article-title":"A comparative study of childhood psoriasis and atopic dermatitis and greater understanding of the overlapping condition, psoriasis-dermatitis","volume":"53","author":"Kapila","year":"2012","journal-title":"Australas. J. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1540-9740.2005.03636.x","article-title":"PsEma\u2014A hitherto unnamed dermatologic entity with clinical features of both psoriasis and eczema","volume":"4","author":"Abramovits","year":"2005","journal-title":"Skinmed"},{"key":"ref_36","first-page":"105","article-title":"Case detection rates of impetigo by gender and age","volume":"20","author":"Kiriakis","year":"2012","journal-title":"Infez. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jaad.2009.07.030","article-title":"Characterization of Staphylococcus aureus cutaneous infections in a pediatric dermatology tertiary health care outpatient facility","volume":"62","author":"Diamantis","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1525-1470.2010.01293.x","article-title":"Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: The San Diego experience","volume":"28","author":"Matiz","year":"2011","journal-title":"Pediatr. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1177\/0009922812441669","article-title":"Addressing antimicrobial resistance to treat children with atopic dermatitis in a tertiary pediatric allergy clinic","volume":"51","author":"Bell","year":"2012","journal-title":"Clin. Pediatr. (Phila)"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jhin.2013.09.006","article-title":"Clinical relevance of mupirocin resistance in Staphylococcus aureus","volume":"85","author":"Hetem","year":"2013","journal-title":"J. Hosp. Infect."},{"key":"ref_41","first-page":"283","article-title":"Diagnosis and management of syphilis","volume":"68","author":"Brown","year":"2003","journal-title":"Am. Fam. Physician"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1128\/CMR.18.1.205-216.2005","article-title":"Secondary syphilitic lesions","volume":"18","author":"Baughn","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaad.2005.08.035","article-title":"The epidemiology of molluscum contagiosum in children","volume":"54","author":"Dohil","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archdermatol.2012.2414","article-title":"Experience with molluscum contagiosum and associated inflammatory reactions in a pediatric dermatology practice: The bump that rashes","volume":"148","author":"Berger","year":"2012","journal-title":"Arch. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e1072","DOI":"10.1542\/peds.2011-1054","article-title":"Recognizing and managing eczematous id reactions to molluscum contagiosum virus in children","volume":"129","author":"Netchiporouk","year":"2012","journal-title":"Pediatrics"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000327888","article-title":"Clinical characteristics of molluscum contagiosum in children in a private dermatology practice in the greater Paris area, France: A prospective study in 661 patients","volume":"222","author":"Osio","year":"2011","journal-title":"Dermatology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jdermsci.2010.09.003","article-title":"Are lifetime prevalence of impetigo, molluscum and herpes infection really increased in children having atopic dermatitis?","volume":"60","author":"Hayashida","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/fampra\/cmt075","article-title":"Epidemiology of molluscum contagiosum in children: A systematic review","volume":"31","author":"Olsen","year":"2014","journal-title":"Fam. Pract."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1525-1470.2010.01356.x","article-title":"The clinical spectrum and therapeutic challenge of eczema herpeticum","volume":"28","author":"Frisch","year":"2011","journal-title":"Pediatr. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jaci.2009.05.020","article-title":"Phenotype of atopic dermatitis subjects with a history of eczema herpeticum","volume":"124","author":"Beck","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.jid.5700657","article-title":"Risk factors of atopic dermatitis patients for eczema herpeticum","volume":"127","author":"Peng","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1525-1470.2012.01859.x","article-title":"Topical corticosteroids and hospital length of stay in children with eczema herpeticum","volume":"30","author":"Aronson","year":"2013","journal-title":"Pediatr. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000018497","article-title":"Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment","volume":"201","author":"Lubbe","year":"2000","journal-title":"Dermatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1346-8138.2007.00326.x","article-title":"Relationship between Kaposi\u2019s varicelliform eruption in Japanese patients with atopic dermatitis treated with tacrolimus ointment and genetic polymorphisms in the IL-18 gene promoter region","volume":"34","author":"Osawa","year":"2007","journal-title":"J. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1542\/peds.2012-3175","article-title":"\u201cEczema coxsackium\u201d and unusual cutaneous findings in an enterovirus outbreak","volume":"132","author":"Mathes","year":"2013","journal-title":"Pediatrics"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/dth.12107","article-title":"Viral exanthems: An update","volume":"26","author":"Biesbroeck","year":"2013","journal-title":"Dermatol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1083-3188(03)00147-5","article-title":"Common pediatric and adolescent skin conditions","volume":"16","author":"Sanfilippo","year":"2003","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"ref_58","first-page":"702","article-title":"Diagnosis and management of tinea infections","volume":"90","author":"Ely","year":"2014","journal-title":"Am. Fam. Physician"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/1059840510375413","article-title":"Facts, fiction, and figures of the Sarcoptes scabiei infection","volume":"26","author":"Orrico","year":"2010","journal-title":"J. Sch. Nurs."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2310\/7750.2009.08091","article-title":"Mycosis fungoides in the pediatric population: Report from an international Childhood Registry of Cutaneous Lymphoma","volume":"14","author":"Pope","year":"2010","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40272-013-0013-9","article-title":"Topical calcineurin inhibitors for atopic dermatitis: Review and treatment recommendations","volume":"15","author":"Carr","year":"2013","journal-title":"Paediatr. Drugs"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2133.2011.10363.x","article-title":"Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors","volume":"165","author":"Tennis","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1525-1470.2011.01497.x","article-title":"A comparative trial comparing the efficacy of tacrolimus 0.1% ointment with Aquaphor ointment for the treatment of keratosis pilaris","volume":"28","author":"Breithaupt","year":"2011","journal-title":"Pediatr. Dermatol."},{"key":"ref_64","first-page":"109","article-title":"Nonsyndromic types of ichthyoses\u2014An update","volume":"12","author":"Traupe","year":"2014","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaad.2008.03.029","article-title":"Clinical detection of ichthyosis vulgaris in an atopic dermatitis clinic: Implications for allergic respiratory disease and prognosis","volume":"59","author":"Bremmer","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_66","first-page":"747","article-title":"Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome","volume":"137","author":"Allen","year":"2001","journal-title":"Arch. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archdermatol.2009.326","article-title":"The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: Results from an exploratory study","volume":"146","author":"Yan","year":"2010","journal-title":"Arch. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1758-2652-14-5","article-title":"New insights into HIV-1-primary skin disorders","volume":"14","author":"Mendez","year":"2011","journal-title":"J. Int. AIDS Soc."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clindermatol.2004.09.011","article-title":"Genetic immunodeficiency disorders","volume":"23","author":"Paller","year":"2005","journal-title":"Clin. Dermatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1155\/2010\/580197","article-title":"Clinical manifestations of hyper IgE syndromes","volume":"29","author":"Freeman","year":"2010","journal-title":"Dis. Markers"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2332\/allergolint.12-RAI-0423","article-title":"Cutaneous manifestations of Hyper IgE syndrome","volume":"61","author":"Minegishi","year":"2012","journal-title":"Allergol. Int."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/MOP.0b013e3283623b9f","article-title":"Cutaneous manifestations of primary immunodeficiency","volume":"25","author":"Kuijpers","year":"2013","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autrev.2013.06.005","article-title":"Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-alpha agents","volume":"13","author":"Fiorino","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0733-8635(18)30206-7","article-title":"Laboratory evaluation of the child with recalcitrant eczema","volume":"12","author":"Hebert","year":"1994","journal-title":"Dermatol. Clin."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1525-1470.2008.00620.x","article-title":"Cutaneous manifestations of cystic fibrosis","volume":"25","author":"Bernstein","year":"2008","journal-title":"Pediatr. Dermatol."},{"key":"ref_76","unstructured":"Pagon, R.A., Adam, M.P., Ardinger, H.H., Bird, T.D., Dolan, C.R., Fong, C.T., Smith, R.J.H., and Stephens, K. (1993\u20132015). Phenylalanine hydroxylase deficiency, GeneReviews\u00ae [Internet], Available online:http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1504."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1053\/j.gastro.2005.02.026","article-title":"Skin manifestations of celiac disease","volume":"128","author":"Zone","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1468-3083.2009.03188.x","article-title":"Guidelines for the diagnosis and treatment of dermatitis herpetiformis","volume":"23","author":"Caproni","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0301-472X(00)00677-9","article-title":"Acute graft-vs.-host disease: Pathobiology and management","volume":"29","author":"Goker","year":"2001","journal-title":"Exp. Hematol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1172-2-35","article-title":"Acute graft versus host disease","volume":"2","author":"Jacobsohn","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1182\/blood.V98.6.1847","article-title":"Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: A study of 121 patients","volume":"98","author":"Muller","year":"2001","journal-title":"Blood"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/4\/5\/884\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:45:53Z","timestamp":1760215553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/4\/5\/884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,6]]},"references-count":81,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5]]}},"alternative-id":["jcm4050884"],"URL":"https:\/\/doi.org\/10.3390\/jcm4050884","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,6]]}}}